Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

High materiality7/10

Picard Medical approves 1-for-50 reverse split to preserve NYSE listing

Jul 21, 2026, 8:51 PM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

Maintains listing risk and may broaden investor access, potentially supporting a near-term re-rating; risk remains that liquidity could dip post-split and that the market views as dilution in the medium term.

AI summary

What happened, with direct paths to the underlying reporting

Picard Medical announced a 1-for-50 reverse stock split to preserve its NYSE American listing, effective July 31, 2026, with split-adjusted trading starting August 3. The move lowers outstanding shares while maintaining ownership, and introduces a new CUSIP 71953R207. Management says the move supports growth plans for the SynCardia Total Artificial Heart and progress on the Emperor platform.

Board approves 1-for-50 reverse stock split; effective July 31; trading Aug 3.
Aims to maintain NYSE American listing; supports SynCardia growth strategy.
No fractional shares issued; rounding up to whole shares; equity awards adjusted.
CEO: advancing STAH adoption and Emperor platform; manufacturing optimization remains priority.
Effective time 5:00 pm ET July 31; split-adjusted trading begins Aug 3.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.